MitraClip: Catheter-based treatment of mitral regurgitation

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023001%3A_____%2F17%3A00076045" target="_blank" >RIV/00023001:_____/17:00076045 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00216224:14110/17:00097417 RIV/65269705:_____/17:00067129

Výsledek na webu

<a href="https://ac.els-cdn.com/S001086501630145X/1-s2.0-S001086501630145X-main.pdf?_tid=1da0601a-acf0-11e7-b296-00000aab0f02&acdnat=1507553475_b5e67f89261b0d2c4bde923f2f838549" target="_blank" >https://ac.els-cdn.com/S001086501630145X/1-s2.0-S001086501630145X-main.pdf?_tid=1da0601a-acf0-11e7-b296-00000aab0f02&acdnat=1507553475_b5e67f89261b0d2c4bde923f2f838549</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1016/j.crvasa.2017.01.015" target="_blank" >10.1016/j.crvasa.2017.01.015</a>

Jazyk výsledku

angličtina

Název v původním jazyce

MitraClip: Catheter-based treatment of mitral regurgitation

Popis výsledku v původním jazyce

Mitral regurgitation (MR) is the second most prevalent heart valve disease requiring surgery. Despite the evidence of unfavourable prognosis, around half of patients with severe MR are not referred for surgery due to high per-operative risk. MitraClip (Abbott Vascular-Structural Heart, Menlo Park, California, United States) implantation is an emerging percutaneous technique with edge-to-edge MV repair inspired by the Alfieri surgery. Favourable safety profile together with improvement of functional status and decrease of MR severity in high-surgical-risk patients have been demonstrated in randomized clinical trials and &quot;real-world&quot; registries for both primary and secondary MR. Our own data confirmed its safety and efficacy comparing to minimally invasive MV surgery in treatment of functional MR in population with severe systolic heart failure.

Název v anglickém jazyce

MitraClip: Catheter-based treatment of mitral regurgitation

Popis výsledku anglicky

Mitral regurgitation (MR) is the second most prevalent heart valve disease requiring surgery. Despite the evidence of unfavourable prognosis, around half of patients with severe MR are not referred for surgery due to high per-operative risk. MitraClip (Abbott Vascular-Structural Heart, Menlo Park, California, United States) implantation is an emerging percutaneous technique with edge-to-edge MV repair inspired by the Alfieri surgery. Favourable safety profile together with improvement of functional status and decrease of MR severity in high-surgical-risk patients have been demonstrated in randomized clinical trials and &quot;real-world&quot; registries for both primary and secondary MR. Our own data confirmed its safety and efficacy comparing to minimally invasive MV surgery in treatment of functional MR in population with severe systolic heart failure.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30201 - Cardiac and Cardiovascular systems

Projekt

—

Návaznosti

V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Rok uplatnění

2017

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Cor et vasa

ISSN

0010-8650

e-ISSN

—

Svazek periodika

59

Číslo periodika v rámci svazku

1

Stát vydavatele periodika

NL - Nizozemsko

Počet stran výsledku

7

Strana od-do

"E85"-"E91"

Kód UT WoS článku

000410029900016

EID výsledku v databázi Scopus

—